Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001422

Director sold 4,720 shares at an average $38.10 ($179,813)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vakiener Victoria Director 2024-01-11 Sale 10b5-1 −3,620 $37.87 $137,089 33,101 D
Vakiener Victoria Director 2024-01-11 Sale 10b5-1 −1,100 $38.84 $42,724 32,001 D
Open-market sales · 4,720 sh · avg $38.10 · $179,813
Loading xslF345X05/wk-form4_1705446365.xml…